3.4. Discrimination of Cancer Stages and Advanced/Metastatic CRC by Combining the Biomarkers of the CD45neg EpCAMpos CTCs, CD45neg EpCAMneg Cell Count, and CEA Level. The gene discussed is CEACAM5; the disease is cancer.